On “The P2 Receptors and Congenital Platelet Function Defects” (Semin Thromb Hemost 2005;31:168-173)

Semin Thromb Hemost 2005; 31(5): 610
DOI: 10.1055/s-2005-922232

LETTER TO THE EDITOR

Christopher O. Nessel¹

¹Executive Director, Clinical Development, The Medicines Company, Parsippany, New Jersey

1 Cattaneo M. The P2 receptors and congenital platelet function defects. Semin Thromb Hemost. 2005; 31 168-173
2 Humphries R G. Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials. Haematologica. 2000; 85 66-72

Christopher O NesselM.D.

Executive Director, Clinical Development, The Medicines Company

8 Campus Drive, Parsippany, NJ 07054